Drug-nutrient interactions of antihypertensives and antidiabetics prescribed at Alcides Carneiro University Hospital

Authors

DOI:

https://doi.org/10.33448/rsd-v9i7.3802

Keywords:

Non-communicable chronic diseases; Nutritional therapy; Pharmacological therapy.

Abstract

Patients affected by hypertension and/or diabetes mellitus may be susceptible to drug-nutrient interactions due to frequent use of medications and possible pharmacological associations. Therefore, the aim of this study was to investigate the possible drug-nutrient interactions – and their respective mechanisms of action – of antihypertensives and antidiabetics prescribed at the Alcides Carneiro University Hospital, as well as to present recommendations that assist health professionals and users in the proper management of these interactions. Therefore, a descriptive exploratory study of qualitative approach was carried out, using the technique of direct observation; which consisted of a contact with the pharmaceutical sector of the hospital to obtain information related to the prescribed drugs, and a subsequent survey in scientific articles, books and electronic bularia to identify their possible interactions with food in general, in addition to the mechanisms that permeate them. Among the total of 18 drugs prescribed for hypertension, important interactions were found for 83.3% (n=15), while of the 5 drugs for the treatment of diabetes, 100% (n=5) demonstrated to have interactions with some food/nutrient. The results contributed to further scientific clarification about the potential interaction of food/nutrients with antihypertensives and antidiabetics and will serve as a search tool for health professionals, especially HUAC, and other stakeholders.

References

Barclay, S., Thomason, J. M., Idle, J. R., & Seymour, R. A. (1992). The incidence and severity of nifedipine‐induced gingival overgrowth. Journal of clinical periodontology, 19(5), 311-314.

Bauer, U. E., Briss, P. A., Goodman, R. A., & Bowman, B. A. (2014). Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA. The Lancet, 384(9937), 45-52.

Benvenuti, S., Cellai, I., Luciani, P., Deledda, C., Baglioni, S., Giuliani, C., ... & Peri, A. (2007). Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells. Journal of endocrinological investigation, 30(9), RC26-RC30.

Brown, R. S., & Arany, P. R. (2015). Mechanism of drug‐induced gingival overgrowth revisited: a unifying hypothesis. Oral diseases, 21(1), e51-e61.

Carlos, G. B., Francisco, L. N., De Moraes, T. C., Cerdeira, C. D., & Santos, G. B. (2017). Análise das possíveis interações fármaco-alimento/nutriente em uma instituição asilar no sul de Minas Gerais. Revista Brasileira de Pesquisa em Saúde/Brazilian Journal of Health Research, 18(3), 83-90.

Chapman, L. E., Darling, A. L., & Brown, J. E. (2016). Association between metformin and vitamin B12 deficiency in patients with type 2 diabetes: A systematic review and metaanalysis. Diabetes & metabolism, 42(5), 316-327.

Cuppari, L. (2005). Guia de nutrição: nutrição clínica do adulto. In Guia de nutrição: nutrição clínica do adulto. São Paulo: Manole.

Dimke, H., Hoenderop, J. G., & Bindels, R. J. (2011). Molecular basis of epithelial Ca2+ and Mg2+ transport: insights from the TRP channel family. The Journal of physiology, 589(7), 1535-1542.

Ferrè, S., Hoenderop, J. G., & Bindels, R. J. (2012). Sensing mechanisms involved in Ca2+ and Mg2+ homeostasis. Kidney international, 82(11), 1157-1166.

Gil, A. C. (2007). Como elaborar projetos de pesquisa. São Paulo: Atlas.

Hanley, M. J., Cancalon, P., Widmer, W. W., & Greenblatt, D. J. (2011). The effect of grapefruit juice on drug disposition. Expert opinion on drug metabolism & toxicology, 7(3), 267-286.

Jeon, H., Jang, I. J., Lee, S., Ohashi, K., Kotegawa, T., Ieiri, I., & Lim, K. S. (2013). Apple juice greatly reduces systemic exposure to atenolol. British journal of clinical pharmacology, 75(1), 172-179.

Kirch, W., & Görg, K. G. (1982). Clinical pharmacokinetics of atenolol—a review. European journal of drug metabolism and pharmacokinetics, 7(2), 81-91.

Knop, J., Misaka, S., Singer, K., Hoier, E., Müller, F., Glaeser, H., ... & Fromm, M. F. (2015). Inhibitory effects of green tea and (–)-epigallocatechin gallate on transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-glycoprotein. PLoS One, 10(10).

Lee, C. T., Chen, H. C., Lai, L. W., Yong, K. C., & Lien, Y. H. H. (2007). Effects of furosemide on renal calcium handling. American Journal of Physiology-Renal Physiology, 293(4), F1231-F1237.

Lima-Calixto, L., & Gonzalez, M. C. (2013). Nutrição clínica no dia a dia. Rio de Janeiro: Editora Rubio.

Lennernas, H., Ahrenstedt, O., & Ungell, A. L. (1994). Intestinal drug absorption during induced net water absorption in man; a mechanistic study using antipyrine, atenolol and enalaprilat. British journal of clinical pharmacology, 37(6), 589-596.

Lilja, J. J., Raaska, K., & Neuvonen, P. J. (2005). Effects of orange juice on the pharmacokinetics of atenolol. European journal of clinical pharmacology, 61(5-6), 337-340.

Livada, R., Shiloah, J. (2014). Calcium channel blocker-induced gingival enlargement. Journal of human hypertension, 28(1), 10-14.

Martins, C., Saeki, S. L. (2013). Interações fármaco x nutriente. Curitiba: Instituto Cristina Martins.

Masaoka, Y., Tanaka, Y., Kataoka, M., Sakuma, S., & Yamashita, S. (2006). Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract. European journal of pharmaceutical sciences, 29(3-4), 240-250.

Mimura, Y., Yasujima, T., Ohta, K., Inoue, K., & Yuasa, H. (2017). Functional identification of plasma membrane monoamine transporter (PMAT/SLC29A4) as an atenolol transporter sensitive to flavonoids contained in apple juice. Journal of pharmaceutical sciences, 106(9), 2592-2598.

Mohn, E. S., Kern, H. J., Saltzman, E., Mitmesser, S. H., & McKay, D. L. (2018). Evidence of drug–nutrient interactions with chronic use of commonly prescribed medications: an update. Pharmaceutics, 10(1), 36.

Morgan, T. (1973). Cinical Use of Potassium Supplements and Potassium Sparing Diuretics. Drugs, 6(3-4), 222-229.

Nijenhuis, T., Vallon, V., van der Kemp, A. W., Loffing, J., Hoenderop, J. G., & Bindels, R. J. (2005). Enhanced passive Ca 2+ reabsorption and reduced Mg 2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. The Journal of clinical investigation, 115(6), 1651-1658.

Otles, S., & Senturk, A. (2014). Food and drug interactions: a general review. Acta Scientiarum Polonorum Technologia Alimentaria, 13(1), 89-102.

Paine, M. F., Widmer, W. W., Pusek, S. N., Beavers, K. L., Criss, A. B., Snyder, J., & Watkins, P. B. (2008). Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine. The American journal of clinical nutrition, 87(4), 863-871.

Paintaud, G., Alvan, G., Eckernäs, S. Å., & Wakelkamp, M. (1995). The influence of food intake on the effect of two controlled release formulations of furosemide. Biopharmaceutics & drug disposition, 16(3), 221-232.

Raebel, M. A., Ellis, J. L., Carroll, N. M., Bayliss, E. A., McGinnis, B., Schroeder, E. B., ... & Steiner, J. F. (2012). Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders. Journal of general internal medicine, 27(1), 57-64.

Reilly, R. F., Huang, C. L. (2011). The mechanism of hypocalciuria with NaCl cotransporter inhibition. Nature Reviews Nephrology, 7(11), 669.

Reis, N. T. (2004). Nutrição clínica: interações. Rio de Janeiro: Rubio.

Samaras, D., Samaras, N., Lang, P. O., Genton, L., Frangos, E., & Pichard, C. (2013). Effects of widely used drugs on micronutrients: a story rarely told. Nutrition, 29(4), 605-610.

Santos, L., Torriani, M. S., & Barros, E. (2013). Medicamentos na prática da farmácia clínica. Porto Alegre: Artmed Editora.

Sanz, M. (2012). Current use of calcium channel blockers (CCBs) is associated with an increased risk of gingival hyperplasia. The journal of evidence-based dental practice, 12(3 Suppl), 147-148.

Sawynok, J. (2011). Methylxanthines and pain. In Methylxanthines. Springer, Berlin, Heidelberg.

Schweigert, I. D., Pletsch, M. U., & Dallepiane, L. B. (2008). Interação medicamentonutriente na prática clínica. Rev. bras. nutr. clín, 72-77.

Silva, S. M. C. S. D., & Mura, J. D. (2007). Tratado de alimentação, nutrição e dietoterapia. São Paulo: Roca.

Sociedade Brasileira de Cardiologia. (2010). VI diretrizes brasileiras de hipertensão. Arq Bras Cardiol, 95(1), 1-51.

Sociedade Brasileira de Diabetes. (2010) E-book "Diabetes na Prática Clínica" da Sociedade Brasileira de Diabetes. Disponível em: https://ebook.diabetes.org.br/component/k2/itemlist/.

World Health Organization. (2017). Noncommunicable diseases progress monitor. Geneva: World Health Organization. Disponível em: https://www.who.int/nmh/publications/ncdprogress-monitor-2017/en/.

Zabłocka-Słowińska, K., Dzielska, E., Gryszkin, I., & Grajeta, H. (2014). Dietary supplementation during diabetes therapy and the potential risk of interactions. Adv Clin Exp Med, 23(6), 939-946.

Published

27/04/2020

How to Cite

PEREIRA, M. T. L.; QUEIROZ, M. P.; BERTOZZO, C. C. de M. S.; BARBOSA, M. Q. E. A.; CAMPOS, R. da S.; PINTO, M. L. M. Drug-nutrient interactions of antihypertensives and antidiabetics prescribed at Alcides Carneiro University Hospital. Research, Society and Development, [S. l.], v. 9, n. 7, p. e35973802, 2020. DOI: 10.33448/rsd-v9i7.3802. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/3802. Acesso em: 16 apr. 2024.

Issue

Section

Health Sciences